Medix Inc. (331A) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Medix Inc. (331A:JPX), powered by AI.

Current Price
¥470
P/E Ratio
3.2
Market Cap
3.5B
Sector
Communication Services
What is the Medix Inc. stock price forecast?

Medix Inc. is currently trading at ¥470. View real-time AI analysis on Alpha Lenz.

What is Medix Inc. insider trading activity?

View the latest insider trading data for Medix Inc. on Alpha Lenz.

What is Medix Inc.'s P/E ratio?

Medix Inc.'s P/E ratio is 3.2.

Medix Inc.

JPX · 331A
¥470-2(-0.42%)Market closedJPX regular session 09:00–15:00 JST
Ask about Medix Inc.'s future dividend policy...
Alpha Chat Insight

Medix Inc. trades at a P/E of 3.2 (undervalued) with strong ROE of 40.5%.

Ask for details

Company Overview

Medix Inc. is a prominent entity within the healthcare sector, focusing on the development and distribution of pharmaceutical products across a global market. Its primary function is to deliver innovative medication solutions that address a range of medical needs, enhancing patient care and outcomes. Medix Inc. is renowned for its investment in research and development, driving advancements in drug therapies for chronic and acute conditions. The company plays a critical role in advancing healthcare technologies and is a key player in the biopharmaceutical industry, contributing to both the scientific community and healthcare market. Through strategic partnerships, Medix Inc. collaborates with healthcare professionals, research institutions, and regulatory bodies to ensure the safe and effective delivery of its products worldwide. As a significant contributor to the pharmaceutical supply chain, Medix Inc. is integral to the ongoing efforts to improve global health standards, demonstrating a commitment to innovation, quality, and sustainability.

SectorCommunication Services
IndustryAdvertising Agencies
0

Company Statistics

FY 2025

Profile

¥3,546,825,860Market Cap
¥4,161,843,000Revenue
0.00Shares Out
0Employees

Margins

89.59%Gross
24.02%EBITDA
19.28%Operating
22.87%Pre-Tax
26.43%Net

Valuation

3.22P/E
1.09P/B
0.85EV/Sales
-0.10EV/EBITDA
7.35P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

17.50%ROA
40.55%ROE
15.18%ROIC

Financial Health

¥3,771,068,000Cash & Cash Equivalents
¥-370,164,000Net Debt
104.05%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Medix Inc. (ticker: 331A) is a company listed on JPX in the Communication Services sector (Advertising Agencies). Market cap is $3.5B.

The current price is 470 with a P/E ratio of 3.22x and P/B of 1.09x.

ROE is 40.55% and operating margin is 19.28%. Annual revenue is $4.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Medix Inc. (331A) Stock Forecast 2026 ¥470 — Price, Financials & Analyst Targets | Alpha Lenz